HCAR2 and hepatocellular carcinoma: A study was conducted to determine the effects of glutamine uptake limitation in hepatocellular carcinoma cells and supplementation with IRE1α/XBP1 signaling or glutamine blockade on the immunosuppressive effects of GPR109A + myeloid cells and tumor progression.